You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Johnson and Johnson
Baxter
AstraZeneca
Mallinckrodt

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

TRIMETH/SULFA Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Trimeth/sulfa, and what generic alternatives are available?

Trimeth/sulfa is a drug marketed by Alpharma Us Pharms and Naska and is included in three NDAs.

The generic ingredient in TRIMETH/SULFA is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.

Summary for TRIMETH/SULFA
Drug patent expirations by year for TRIMETH/SULFA
Synonyms for TRIMETH/SULFA
[(4-aminophenyl)sulfonyl](5-methylisoxazol-3-yl)amine
08D
129378-89-8
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(para-Aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzene-1-sulfonamide
4-amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide; N1-(5-Methylisoxazol-3-yl)sulfanilamide
4-AMINO-N-(5-METHYL-3-ISOXAZOYL)BENZENESULFONAMIDE
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzene sulfonamide
4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide
4-amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide
4-AMINO-N-[5-METHYL-3-ISOXAZOLYL]BENZENESULFONAMID
4563-84-2
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
723-46-6
A047
AB00052099
AB00052099_17
AB00052099_18
AB00052099-14
AB00052099-16
AB1009297
AC-11118
AK-36221
AKOS000200952
ALBB-002089
ANW-43073
ARONIS018156
Azo-gantanol
Bactrim
Bactrimel
BB 0242379
BBL004554
BCP02881
BCP0726000283
BDBM50029770
Benzenesulfonamide, 4-amino-N-(5-methyl-3-isoxazolyl)-
BIDD:GT0731
BPBio1_000081
BRD-K28494619-001-05-0
BRD-K28494619-001-15-9
BRD-K28494619-001-26-6
BRN 0226453
BS-3542
BSPBio_000073
BSPBio_002028
C07315
C10H11N3O3S
CAS-723-46-6
CCG-40166
CCRIS 567
CHEBI:9332
CHEMBL443
Co-trimoxazole (Salt/Mix)
component of Azo Gantanol (Salt/Mix)
component of Bactrim (Salt/Mix)
CPD000058223
CS-2363
CTK5D5959
D00447
DB-055629
DB01015
DivK1c_000649
DSSTox_CID_6064
DSSTox_GSID_26064
DSSTox_RID_78001
DTXSID8026064
EBD3403
EINECS 211-963-3
Epitope ID:114999
Eusaprim (Salt/Mix)
FT-0602616
Gamazole
Gantanol
Gantanol-DS
H463
HMS1568D15
HMS1921A21
HMS2092K03
HMS2095D15
HMS2233L13
HMS3259E06
HMS3372M22
HMS3655O22
HMS3712D15
HMS502A11
HMS561O18
HSDB 3186
HTS001394
HY-B0322
IDI1_000649
InChI=1/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)
J10090
JE42381TNV
JLKIGFTWXXRPMT-UHFFFAOYSA-
JLKIGFTWXXRPMT-UHFFFAOYSA-N
KBio1_000649
KBio2_001474
KBio2_004042
KBio2_006610
KBio3_001528
KBioGR_000749
KBioSS_001474
KM1475
KS-000000QU
KS-00004AEJ
KSC635S5T
LS-1620
Maybridge1_007190
MCULE-1450176600
Metoxal
MFCD00010546
MLS000069732
MLS001055354
MLS001074165
MLS006011871
MS 53
N^1-(5-Methyl-3-isoxazolyl)-Sulfanilamide
N'-(5-Methyl-3-isoxazole)sulfanilamide
N'-(5-Methyl-3-isoxazolyl)-Sulfanilamide
N'-(5-Methyl-3-isoxazolyl)sulfanilamide
N'-(5-Methylisoxazol-3-yl)sulphanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N(sup 1)-(5-Methyl-3-isoxazolyl)sulphanilamide
N(sup1)-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-methyl-3-isoxazolyl)-Sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
N1-(5-methylisoxazol-3-yl)-4-aminobenzene-1-sulfonamide
N1-(5-Methylisoxazol-3-yl)sulfanilamide
NC00537
NCGC00016533-01
NCGC00016533-02
NCGC00016533-03
NCGC00016533-04
NCGC00016533-05
NCGC00016533-06
NCGC00016533-07
NCGC00016533-08
NCGC00016533-09
NCGC00016533-10
NCGC00016533-11
NCGC00016533-12
NCGC00016533-14
NCGC00021995-03
NCGC00021995-04
NCGC00021995-05
NCGC00186654-01
NCGC00257907-01
Ndimethyl1-(5-methyl-3-isoxazolyl)-Sulfanilamide
NINDS_000649
NSC 147832
NSC-147832
NSC-757328
NSC147832
NSC757328
Opera_ID_882
Oprea1_114486
Oprea1_285680
Pharmakon1600-01500550
Prestwick_453
Prestwick0_000177
Prestwick1_000177
Prestwick2_000177
Prestwick3_000177
Q-201762
Q415843
Radonil
Ro 4-2130
Ro 6-2580/11
Ro-4-2130
Ro-42130
RTR-023663
S0361
s1915
SAM002554930
SBB057675
SBB071655
SBI-0051524.P003
SC-15160
SCHEMBL3656
Septran (Salt/Mix)
Septrin (Salt/Mix)
Simsinomin
Sinomin
SMR000058223
SMX
Solfametossazolo
Solfametossazolo [DCIT]
SPBio_000896
SPBio_001994
Spectrum_000994
SPECTRUM1500550
Spectrum2_000788
Spectrum3_000584
Spectrum4_000345
Spectrum5_000982
SR-01000000217
SR-01000000217-2
SR-01000000217-3
ST024740
ST2418109
ST51006798
STK007988
STX 608
STX-608
Sulfamethalazole
Sulfamethoxazol
sulfamethoxazole
SULFAMETHOXAZOLE (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE); TMP/SMX (MIXTURE))
Sulfamethoxazole (JP17/USP/INN)
Sulfamethoxazole [USAN:INN:JAN]
Sulfamethoxazole [USAN:USP:INN:BAN:JAN]
Sulfamethoxazole, analytical standard
Sulfamethoxazole, British Pharmacopoeia (BP) Reference Standard
Sulfamethoxazole, certified reference material, TraceCERT(R)
Sulfamethoxazole, European Pharmacopoeia (EP) Reference Standard
Sulfamethoxazole, Pharmaceutical Secondary Standard; Certified Reference Material
Sulfamethoxazole, United States Pharmacopeia (USP) Reference Standard
Sulfamethoxazole, VETRANAL(TM), analytical standard
Sulfamethoxazole,(S)
Sulfamethoxazole(USAN)
Sulfamethoxazolum
Sulfamethoxazolum [INN-Latin]
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfametoxazol [INN-Spanish]
Sulfanilamide, N'-(5-methyl-3-isoxazolyl)-
Sulfanilamide, N(1)-(5-methyl-3-isoxazolyl)-
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)-
Sulfanilamide, N1-(5-methyl-3-isoxazolyl)- (8CI)
Sulfisomezole
Sulmeprim
Sulpha-methoxizole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethylisoxazole
Sulphisomezole
SW196670-3
Tox21_110480
Tox21_110480_1
Tox21_200353
TRA0076970
UNII-JE42381TNV
Urobak
WLN: T5NOJ C1 EMSWR DZ
Z57198677
ZINC89763

US Patents and Regulatory Information for TRIMETH/SULFA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alpharma Us Pharms TRIMETH/SULFA sulfamethoxazole; trimethoprim SUSPENSION;ORAL 072289-001 May 23, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Alpharma Us Pharms TRIMETH/SULFA sulfamethoxazole; trimethoprim SUSPENSION;ORAL 072398-001 May 23, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Naska TRIMETH/SULFA sulfamethoxazole; trimethoprim SUSPENSION;ORAL 072399-001 May 23, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Johnson and Johnson
Baxter
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.